Carlos Moliner-Abos
Overview
Explore the profile of Carlos Moliner-Abos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salido M, Moliner C, Moliner-Abos C, Zoratti L, Puig T, Carreras-Costa F, et al.
Int J Cardiol
. 2025 Feb;
427:133060.
PMID: 40010514
Background: The presence of ventricular repolarization abnormalities (VRA) in young asymptomatic athletes is rare and may represent initial expression of underlying ongoing cardiomyopathy, increasing risk of sudden cardiac death. This...
2.
Moliner-Abos C, Santalo-Corcoy M, Meseguer-Donlo J, Crehuet-Llonch A, Campos Garcia B, Mirabet Perez S
Rev Esp Cardiol (Engl Ed)
. 2025 Jan;
PMID: 39855462
No abstract available.
3.
Moliner-Abos C, Calvo-Barcelo M, Sole-Gonzalez E, Borrellas Martin A, Fluvia-Brugues P, Sanchez-Vega J, et al.
Eur J Heart Fail
. 2024 Oct;
PMID: 39359034
Aims: Despite numerous trials on revascularization in patients with heart failure (HF) and ischaemic left ventricular (LV) dysfunction, its role remains unsettled. Guideline-directed medical therapy (GDMT) for HF has shown...
4.
Bermudez-Jimenez F, Protonotarios A, Garcia-Hernandez S, Perez Asensio A, Rampazzo A, Zorio E, et al.
JACC Clin Electrophysiol
. 2024 May;
10(6):1178-1190.
PMID: 38727660
Background: Desmin (DES) pathogenic variants cause a small proportion of arrhythmogenic cardiomyopathy (ACM). Outcomes data on DES-related ACM are scarce. Objectives: This study sought to provide information on the clinical...
5.
Moliner-Abos C, Alberti-Vall B, Millan-Alvarez X, Camps-Renom P, Guasch-Jimenez M, Asmarats-Serra L, et al.
J Stroke Cerebrovasc Dis
. 2023 Dec;
33(2):107481.
PMID: 38064973
Background: Patients with atrial fibrillation (AF) and intracerebral hemorrhage (ICH) are at high risk of ischemic and recurrent bleeding events. Therefore, the decision of restarting or avoiding anticoagulation is challenging....
6.
Cliville D, Moliner-Abos C, Gallego I, Camprecios M
Eur Heart J Case Rep
. 2023 Oct;
7(10):ytad432.
PMID: 37841048
Background: Myocarditis is an infrequent extrapulmonary manifestation of tuberculosis that confers an unfavourable prognosis. Case Summary: A 36-year-old man presented to the hospital with palpitations and dyspnoea. Tests revealed the...
7.
de Juan Baguda J, de Frutos F, Lopez-Vilella R, Couto Mallon D, Guzman-Bofarull J, Blazquez-Bermejo Z, et al.
Rev Esp Cardiol (Engl Ed)
. 2023 Jul;
77(4):290-301.
PMID: 37516313
Introduction And Objectives: Repetitive ambulatory doses of levosimendan are an option as a bridge to heart transplantation (HT), but evidence regarding the safety and efficacy of this treatment is scarce....
8.
Dobarro D, Donoso-Trenado V, Sole-Gonzalez E, Moliner-Abos C, Garcia-Pinilla J, Lopez-Fernandez S, et al.
ESC Heart Fail
. 2023 Jan;
10(2):1193-1204.
PMID: 36655614
Aim: Patients with advanced heart failure (AHF) who are not candidates to advanced therapies have poor prognosis. Some trials have shown that intermittent levosimendan can reduce HF hospitalizations in AHF...